Alterity Therapeutics (ATHE) Return on Assets (2020 - 2022)

Alterity Therapeutics (ATHE) has reported Return on Assets for 9 consecutive years, with 0.0% the latest figure, recorded in Q2 2021.

• In Q2 2021, Return on Assets rose 2.0% year-over-year to 0.0%; the TTM figure through Jun 2021 stood at 0.0% (up 2.0% YoY), while the FY2023 annual figure was 5466.86%, down 546686.0% from the prior year.
• Return on Assets came in at 0.0% for Q2 2021 at Alterity Therapeutics, up from 0.0% in the prior quarter.
• The five-year high for Return on Assets was 0.0% in Q2 2017, with the low at 0.02% in Q2 2020.
• Average Return on Assets over 5 years is 0.01%, with a median of 0.0% recorded in 2021.
• Across the five-year window, Return on Assets slipped 2 bps in 2020 and grew 2 bps in 2021, its largest moves.
• Year by year, Return on Assets stood at 0.0% in 2017, then sank by 132 bps to 0.0% in 2018, then plunged by 53482 bps to 0.01% in 2019, then soared by 65 bps to 0.0% in 2020, then surged by 36 bps to 0.0% in 2021.
• According to Business Quant data, Return on Assets over the past three periods registered 0.0%, 0.0%, and 0.02% for Q2 2021, Q4 2020, and Q2 2020 respectively.